Skip to content

BERTOPEDICS

Active Private limited companyfounded 2015active for 11 yearsStraal 15, 2491 BalenKBO/BCE: BE 0627.633.154

Annual accounts 2025

micro format, filed on 10-07-2026, 21 days before the deadline
€41,578
▼ 6.7%
€25,804
▼ 16.0%
€15,596
▼ 16.7%
€50,038
▼ 27.5%
49.2%
▼ 13.8 percentage points
1.91
▼ 1.50

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €370,000. Estimated: probably between €210,000 and €630,000.

Balance sheet

balance sheet total €136,792 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

49.2%

Higher than 64% of 25,388 companies in 2025.

1.91

Higher than 62% of 24,385 companies in 2025.

11.4%

Higher than 73% of 24,575 companies in 2025.

BERTOPEDICS Middle half of the sector 80% of the sector Micro accounts in retail trade (NACE 47)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023
Balance sheet: assets
20/58 136,792142,171137,106
21/28 32,02344,57253,418
22/27 32,02344,57253,418
23 3,0923,912-
24 28,93140,66053,418
29/58 104,76997,59983,689
29 33,3597,0581,001
291 33,3597,0581,001
40/41 15,49325,145997
40 15,49312,3200
41 012,824997
54/58 55,25763,49279,365
490/1 6591,9042,326
Balance sheet: equity and liabilities
10/49 136,792142,171137,106
10/15 67,31189,63870,922
10/11 1,0001,0001,000
13 66,31150,71531,999
130/1 --0
1311 --0
133 66,31150,71531,999
14 037,92337,923
17/49 69,48052,53266,184
17 14,75023,96332,708
170/4 14,75023,96332,708
42/48 54,73028,57032,591
42 9,2128,7459,426
44 5,4256,4383,343
440/4 5,4256,4383,343
45 9,94313,38719,822
450/3 9,94313,38719,822
47/48 30,150-0
492/3 -0886
Income statement
76A --8,693
9900 41,57844,56544,647
62 1,779--
630 12,54912,9468,313
640/8 1,4478861,889
9901 25,80430,73334,446
75/76B 31636050
75 31636050
65/66B 1,6382,0181,367
65 1,6382,0181,367
9903 24,48129,07533,129
67/77 8,88510,35914,744
9904 15,59618,71618,386
9905 15,59618,71618,386
Appropriation of the result
9906 15,59656,63956,309
14P 037,92337,923
691/2 15,59618,71618,386
6921 15,59618,71618,386
Document PDFPDFPDF

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 10-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 10-07-2026 2026-00279981 PDF
31-12-2024 micro format 08-07-2025 2025-00255249 PDF
31-12-2023 micro format 25-07-2024 2024-00291283 PDF

Subsidies and aid

Flemish government 2025, 1 entry, €150 awarded, €150 paid

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023
38,35343,67942,758
28,14531,66226,698
04,10058,645
-8,235-15,873-
50,03869,02951,098
49.2%63.0%51.7%
1.913.422.57
1.030.590.93
23.2%20.9%25.9%
11.4%13.2%13.4%
23.4121.6531.29

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item202520242023
Tangible fixed assets-€4,100€58,645
€12,549€12,946€8,313

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Insights on BERTOPEDICS

The operating result for 2025 is 16% lower than in 2024 and the lowest since 2023. It is the second fall in a row.

Debt's share of the balance-sheet total rises from 37.0% to 50.8%. Equity is lower and debt is higher.

Next steps